rethinkPeptides Search
Menu
Study breakdown

Tachykinin Peptides Surge in the Rat Uterus Around the Time of Embryo Implantation

evidence
The takeaway

Substance P, neurokinin B, and their receptors are actively produced in the rat uterus during early pregnancy, with expression peaking around the time of embryo implantation — especially in decidual cells.

Days 1-9 of pregnancy

Tachykinin expression underwent major changes during this critical window, peaking around embryo implantation with particular concentration in decidual cells

What the researchers found

All tachykinins and tachykinin receptors examined were found to be locally synthesized in the uterus of early pregnant rats (Days 1-9). Substance P, neurokinin B, and receptors NK1R and NK3R showed major expression changes during the days surrounding implantation.

These peptides and receptors were widely distributed in implantation sites and were particularly abundant in decidual cells — the maternal cells that nourish and support the early embryo. Previous work by the same group showed that blocking the NK3R receptor reduced litter size in rats, supporting a functional role for these peptides in reproduction.

Why it matters

Embryo implantation failure is a leading cause of infertility and early pregnancy loss. Understanding which molecular signals coordinate this critical process could lead to new diagnostic tools and treatments. This study identifies tachykinin peptides as potential key players in implantation, which could eventually inform fertility treatments or contraceptive strategies.

How the study worked

Uterine samples were collected from early pregnant rats (Days 1-9 of pregnancy) and from non-pregnant rats during the proestrus stage of the ovarian cycle. The researchers used three complementary techniques: real-time quantitative RT-PCR to measure mRNA levels, immunohistochemistry to visualize protein location in tissue sections, and Western blot to quantify protein levels of tachykinins and their receptors.

What this study cannot tell us

This is an animal study in rats, and the findings may not directly translate to human reproductive biology. The study characterized expression patterns but did not perform functional experiments to prove that the tachykinins are required for implantation. Previous work by the group showed NK3R antagonism reduced litter size, but the mechanism linking tachykinin signaling to implantation success was not established in this study.

How to read the evidence

This is an animal study using well-established molecular biology techniques (RT-qPCR, immunohistochemistry, Western blot) to characterize gene and protein expression. It provides solid preclinical evidence for tachykinin involvement in implantation, supported by prior functional data from NK3R blockade studies.

When this study was published

Published in 2015, this study represents foundational work on tachykinin peptides in reproductive biology that continues to inform current research on peptide signaling in fertility.

The bigger picture

This research connects the tachykinin peptide system — traditionally studied in pain and inflammation — to reproductive biology. It's part of a growing body of work showing that neuropeptides play crucial roles in fertility beyond the brain, acting locally in reproductive tissues to coordinate events like implantation. Understanding these peptide pathways could reveal new targets for both fertility enhancement and non-hormonal contraception.

Questions still open

  • Do the same tachykinin expression patterns occur in the human uterus during early pregnancy?
  • Could targeting tachykinin receptors improve implantation rates in IVF or other fertility treatments?
  • What is the specific mechanism by which substance P and neurokinin B support embryo implantation?

Common questions

What are tachykinins and what do they usually do?
Tachykinins are a family of small peptides — including substance P and neurokinin B — best known for their roles in pain signaling and inflammation. This study shows they also play important roles in the uterus during early pregnancy, particularly around the time when the embryo implants into the uterine wall.
Could these findings help people with fertility problems?
Potentially, in the future. If tachykinin peptides prove to be essential for embryo implantation in humans — not just rats — then boosting or modulating their activity could become a strategy for improving IVF success rates or treating implantation failure. However, much more research is needed before any clinical applications.

Read the original research

Analysis of the Expression of Tachykinins and Tachykinin Receptors in the Rat Uterus During Early Pregnancy.

Biology of reproduction, 93(2), 51

Citation

Pinto, Francisco M; Bello, Aixa R; Gallardo-Castro, Manuel; Valladares, Francisco; Almeida, Teresa A; Tena-Sempere, Manuel; Candenas, Luz. (2015). Analysis of the Expression of Tachykinins and Tachykinin Receptors in the Rat Uterus During Early Pregnancy.. Biology of reproduction, 93(2), 51. https://doi.org/10.1095/biolreprod.115.130617